Literature DB >> 14686332

European guidelines on cardiovascular disease and prevention in clinical practice.

Guy De Backer, Ettore Ambrosioni, Knut Borch-Johnsen, Carlos Brotons, Renata Cifkova, Jean Dallongeville, Shah Ebrahim, Ole Faergeman, Ian Graham, Giuseppe Mancia, Volkert Manger Cats, Kristina Orth-Gomér, Joep Perk, Kalevi Pyörälä, José L Rodicio, Susana Sans, Vedat Sansoy, Udo Sechtem, Sigmund Silber, Troels Thomsen, David Wood.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14686332     DOI： 10.1016/j.atherosclerosis.2003.10.001

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  24 in total

1.  Canadian Cardiovascular Society position statement--recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease.

Authors:  Ruth McPherson; Jiri Frohlich; George Fodor; Jacques Genest
Journal:  Can J Cardiol       Date:  2006-09       Impact factor: 5.223

2.  Serum Lipid Profile: Fasting or Non-fasting?

Authors:  P K Nigam
Journal:  Indian J Clin Biochem       Date:  2010-12-29

3.  Selective thyroid receptor modulation by GC-1 reduces serum lipids and stimulates steps of reverse cholesterol transport in euthyroid mice.

Authors:  Lisen Johansson; Mats Rudling; Thomas S Scanlan; Thomas Lundåsen; Paul Webb; John Baxter; Bo Angelin; Paolo Parini
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-08       Impact factor: 11.205

Review 4.  Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey.

Authors:  Richard Kones
Journal:  Drug Des Devel Ther       Date:  2011-06-13       Impact factor: 4.162

Review 5.  Effects of Lipid Structure Changed by Interesterification on Melting Property and Lipemia.

Authors:  Tong Wang; Xiaosan Wang; Xingguo Wang
Journal:  Lipids       Date:  2016-08-24       Impact factor: 1.880

Review 6.  Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.

Authors:  Richard Kones
Journal:  Vasc Health Risk Manag       Date:  2010-09-07

7.  Lipid-lowering drug use in Italian primary care: effects of reimbursement criteria revision.

Authors:  G Trifirò; M Alacqua; S Corrao; S Moretti; D U Tari; M Galdo; A P Caputi; V Arcoraci
Journal:  Eur J Clin Pharmacol       Date:  2008-06       Impact factor: 2.953

8.  Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women.

Authors:  Samia Mora; James D Otvos; Nader Rifai; Robert S Rosenson; Julie E Buring; Paul M Ridker
Journal:  Circulation       Date:  2009-02-09       Impact factor: 29.690

9.  Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events.

Authors:  Samia Mora; Nader Rifai; Julie E Buring; Paul M Ridker
Journal:  Circulation       Date:  2008-08-18       Impact factor: 29.690

10.  Serum lipid profile constituents as markers of cardiovascular morbidity in patients on chronic hemodialysis.

Authors:  Dimitrios Kirmizis; Evangelia Koutoupa; Apostolos Tsiandoulas; Aphroditi Valtopoulou; Georgios Niavis; Phani Markou; Konstantinos Barboutis
Journal:  Biomark Insights       Date:  2007-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.